| 71.49 0.87 (1.23%) | 12-05 10:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 85.48 | 1-year : | 99.84 |
| Resists | First : | 73.18 | Second : | 85.48 |
| Pivot price | 70  |
|||
| Supports | First : | 66.33 |
Second : | 62.09 |
| MAs | MA(5) : | 70.61  |
MA(20) : | 69.72 |
| MA(100) : | 94.62 |
MA(250) : | 0 | |
| MACD | MACD : | -2.5 |
Signal : | -3.7 |
| %K %D | K(14,3) : | 58.9 |
D(3) : | 58 |
| RSI | RSI(14): 42.1 |
|||
| 52-week | High : | 146.36 | Low : | 62 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ITGR ] has closed below upper band by 37.1%. Bollinger Bands are 58% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 71.2 - 71.63 | 71.63 - 72.05 |
| Low: | 68.8 - 69.31 | 69.31 - 69.79 |
| Close: | 69.84 - 70.59 | 70.59 - 71.31 |
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Thu, 04 Dec 2025
Integer Holdings Corporation $ITGR Position Boosted by Quantbot Technologies LP - MarketBeat
Thu, 04 Dec 2025
Capital Fund Management S.A. Takes Position in Integer Holdings Corporation $ITGR - MarketBeat
Wed, 03 Dec 2025
Transcript : Integer Holdings Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 09 - marketscreener.com
Wed, 03 Dec 2025
Integer Holdings Seeks Acquisitions - marketscreener.com
Wed, 03 Dec 2025
What Does Integer Holdings Corporation's (NYSE:ITGR) Share Price Indicate? - 富途牛牛
Wed, 03 Dec 2025
Integer Holdings Insiders Sold US$33m Of Shares Suggesting Hesitancy - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 35 (M) |
| Shares Float | 35 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 113.6 (%) |
| Shares Short | 2,730 (K) |
| Shares Short P.Month | 2,620 (K) |
| EPS | 2.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 49.83 |
| Profit Margin | 4.7 % |
| Operating Margin | 14.2 % |
| Return on Assets (ttm) | 4.6 % |
| Return on Equity (ttm) | 5.1 % |
| Qtrly Rev. Growth | 8.3 % |
| Gross Profit (p.s.) | 14.18 |
| Sales Per Share | 52.22 |
| EBITDA (p.s.) | 10.49 |
| Qtrly Earnings Growth | 12.5 % |
| Operating Cash Flow | 204 (M) |
| Levered Free Cash Flow | 161 (M) |
| PE Ratio | 29.15 |
| PEG Ratio | 0 |
| Price to Book value | 1.42 |
| Price to Sales | 1.35 |
| Price to Cash Flow | 12.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|